R1507, a fully human monoclonal antibody targeting IGF‐1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts

E. Anders Kolb(Alfred I. duPont Hospital for Children), Richard Görlick(Albert Einstein College of Medicine)

Pediatric Blood & Cancer

March 27, 2010

10.1002/pbc.22479

Cited by 82

Related Papers

Platelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

|Cancer|2008|114

HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival

|Scientific Reports|2016|106